MoLEP—Co-creating a Mycobacterium leprae transmission interruption program for the Morogoro region, Tanzania

The global goal for leprosy elimination is the interruption of Mycobacterium leprae transmission, resulting in zero new leprosy patients. In alignment with this objective, Tanzania's updated national leprosy strategy emphasizes early detection, systematic contact tracing, post-exposure prophylaxis (PEP) with single-dose rifampicin (SDR), and integration of services into primary health care. However, the feasibility of accelerating M. leprae transmission interruption in high-burden areas with this strategy has yet to be demonstrated. In 2024, the Morogoro Leprosy Elimination Program (MoLEP) was launched in the country's most endemic region. Developed through a collaborative process, MoLEP aligns global practices with local conditions and needs. Key interventions include training frontline health workers and expanding contact tracing with SDR-PEP. Furthermore, targeted activities will respond to high transmission areas and the detection of child cases, which serve as indicators of recent transmission. Strengthening the drug supply chain is also a priority. MoLEP will generate critical data on the feasibility and effectiveness of these interventions in accelerating progress toward elimination. The implementation is guided by a comprehensive monitoring and evaluation framework, alongside clearly defined governance structures, to facilitate evidence-informed decision-making. Findings are expected to guide strategic scaling and replication in other high-burden regions across Tanzania and beyond.

Authors

Institutions

Publication Details

Journal
PLoS neglected tropical diseases
Published
2025-09-19
DOI
https://doi.org/10.1371/journal.pntd.0013507
Primary Topic
Leprosy Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MoLEP—Co-creating a Mycobacterium leprae transmission interruption program for the Morogoro region, Tanzania

Peter Steinmann, Tanja Barth‐Jaeggi, Riziki Kisonga, Issa Garimo et al.
PLoS neglected tropical diseases
Leprosy Research and Treatment
article

MoLEP—Co-creating a Mycobacterium leprae transmission interruption program for the Morogoro region, Tanzania

Peter Steinmann, Tanja Barth‐Jaeggi, Riziki Kisonga, Issa Garimo, Liberate Mleoh, John Msaki, Sherzana Sunderji, G. Coulon, Kihulya Mageda, Shaishav Panchal, Sunil Modali, Shigela Marco Njebele
article en

Abstract

The global goal for leprosy elimination is the interruption of Mycobacterium leprae transmission, resulting in zero new leprosy patients. In alignment with this objective, Tanzania's updated national leprosy strategy emphasizes early detection, systematic contact tracing, post-exposure prophylaxis (PEP) with single-dose rifampicin (SDR), and integration of services into primary health care. However, the feasibility of accelerating M. leprae transmission interruption in high-burden areas with this strategy has yet to be demonstrated. In 2024, the Morogoro Leprosy Elimination Program (MoLEP) was launched in the country's most endemic region. Developed through a collaborative process, MoLEP aligns global practices with local conditions and needs. Key interventions include training frontline health workers and expanding contact tracing with SDR-PEP. Furthermore, targeted activities will respond to high transmission areas and the detection of child cases, which serve as indicators of recent transmission. Strengthening the drug supply chain is also a priority. MoLEP will generate critical data on the feasibility and effectiveness of these interventions in accelerating progress toward elimination. The implementation is guided by a comprehensive monitoring and evaluation framework, alongside clearly defined governance structures, to facilitate evidence-informed decision-making. Findings are expected to guide strategic scaling and replication in other high-burden regions across Tanzania and beyond.

PLoS neglected tropical diseasesVol. 19(9)
Swiss Tropical and Public Health Institute (CH), University of Basel (CH), Novartis (India) (IN), Kenya School of Government (KE), Ministry of Education and Vocation Training (TZ), Netherlands Leprosy Relief (NL), Novartis (United Kingdom) (GB)
Openalex Percentile: Top 70%
Leprosy Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.